Nothing Special   »   [go: up one dir, main page]

BR9612317A - Análogos nucleotìdeos. - Google Patents

Análogos nucleotìdeos.

Info

Publication number
BR9612317A
BR9612317A BR9612317-6A BR9612317A BR9612317A BR 9612317 A BR9612317 A BR 9612317A BR 9612317 A BR9612317 A BR 9612317A BR 9612317 A BR9612317 A BR 9612317A
Authority
BR
Brazil
Prior art keywords
nucleotide analogues
nucleotide
analogs
nucleotide analog
nucleotyde
Prior art date
Application number
BR9612317-6A
Other languages
English (en)
Inventor
Murty N Arimilli
Norbert W Bischofberger
Robert J Jones
William A Lee
Ernest J Prisbe
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/581,147 external-priority patent/US5886179A/en
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of BR9612317A publication Critical patent/BR9612317A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Patente de Invenção: <B>"ANáLOGOS NUCLEOTìDEOS"<D>. ésteres de nucleotídeos fosfonados caracterizados pela presença de um grupo éster ligado, o qual está ligado ao átomo de fósforo de um análogo nucleotídeo são aqui descritos. Os análogos compreedem um éster ligado que é hidrolisado in vivo para render uma análogo nucleotídeo fosfonato correspondente. Métodos e intermediários para suas sínteses e uso são descritos.
BR9612317-6A 1995-12-29 1996-12-13 Análogos nucleotìdeos. BR9612317A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US937595P 1995-12-29 1995-12-29
US937295P 1995-12-29 1995-12-29
US08/581,147 US5886179A (en) 1993-09-17 1995-12-29 Nucleotide analogs
PCT/US1996/020226 WO1997024361A1 (en) 1995-12-29 1996-12-13 Nucleotide analogs

Publications (1)

Publication Number Publication Date
BR9612317A true BR9612317A (pt) 2000-10-31

Family

ID=27358844

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9612317-6A BR9612317A (pt) 1995-12-29 1996-12-13 Análogos nucleotìdeos.

Country Status (6)

Country Link
EP (1) EP0874858A1 (pt)
AU (1) AU1427097A (pt)
BR (1) BR9612317A (pt)
CA (1) CA2239020A1 (pt)
NZ (1) NZ325704A (pt)
WO (1) WO1997024361A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2627903T3 (es) 2000-07-21 2017-08-01 Gilead Sciences, Inc. Profármacos de análogos de nucleótidos de fosfonato y métodos para seleccionar y preparar los mismos
CN102485229B (zh) * 2010-12-02 2015-09-02 中国人民解放军军事医学科学院毒物药物研究所 抗病毒药物
CN107312039B (zh) 2012-08-30 2019-06-25 江苏豪森药业集团有限公司 一种替诺福韦前药的制备方法
CN103923124A (zh) * 2013-01-15 2014-07-16 中国人民解放军军事医学科学院毒物药物研究所 结晶态的抗乙肝病毒药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801729D0 (sv) * 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
EP0405748A1 (en) * 1989-05-30 1991-01-02 Beecham Group p.l.c. Phosphonoderivative of purine with antiviral activity
DK0481214T3 (da) * 1990-09-14 1999-02-22 Acad Of Science Czech Republic Prolægemidler af phosphonater
CA2171743C (en) * 1993-09-17 2007-11-20 Norbert W. Bischofberger Nucleotide analogs

Also Published As

Publication number Publication date
EP0874858A1 (en) 1998-11-04
AU1427097A (en) 1997-07-28
CA2239020A1 (en) 1997-07-10
NZ325704A (en) 2000-02-28
WO1997024361A1 (en) 1997-07-10

Similar Documents

Publication Publication Date Title
ATE486882T1 (de) Nukleotidanaloge
KR960034178A (ko) 벤자제핀- 벤즈옥사제핀- 및 벤조티아제핀-n- 아세트산 유도체와 그 제조방법 및 그들을 함유한 약제학적 조성물
ES2022610B3 (es) Compuestos para potenciar la permeabilidad de la piel que utilizan esteres de sacarosa.
ES2186961T3 (es) Derivados de acido benzazepinona-n-acetico sustituidos por acido fosfonico, asi como procedimiento para su preparacion y medicamentos que contienen estos compuestos.
ES478803A1 (es) Un procedimiento para la preparacion de derivados de acila- dos de muramil peptidos.
DK0956033T3 (da) Totalsyntese af amino-Hip-analogen af didemnin A
NZ333226A (en) Immunstimulating lipid formulation
MX168030B (es) Procedimiento para la preparacion de derivados de alcano y alcoxialcano
DK134889D0 (da) Overfladeaktive forbindelser og fremgangsmaade til fremstilling deraf
DE69016567D1 (de) Prostaglandinanaloge enthaltende Lipidemulsion.
BR9612317A (pt) Análogos nucleotìdeos.
ATE49957T1 (de) Adamantanamin-derivate, verfahren zur herstellung und diese enthaltende heilmittel.
ATE258933T1 (de) Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
CO4700282A1 (es) Compuestos
ATE60768T1 (de) Verfahren zur herstellung von thienylaethylaminen, und mittels des verfahrens hergestellte dithienylaethylamine.
CA2095642A1 (en) Adhesion receptors for pathogenic or opportunistic microorganisms
HK1003785A1 (en) Mono esters of dicarboxylic acids their preparation and use
BG104427A (en) Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
ES2127278T3 (es) Preparados de acidos 2-aril-propionicos y procedimiento para su produccion.
EP0374513A3 (en) Novel bis-arylphosphate ester antagonists of platelet activating factor
ES2188842T3 (es) Esterquats.
ES2051766T3 (es) Antigestagenos para la inhibicion de la sintesis uterina de prostaglandinas.
KR900009533A (ko) 아릴아세트산 모노 에스테르 및 그의 제조방법
DE60021500D1 (de) Herstellung von Thiophosphonoformatestern
AU4019189A (en) Esters of 3-demethylthiocolchicine and n-acyl analogs

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]